Disclosures for "Comparative Efficacy of MEK Inhibitors in Neurofibromatosis Type One–Associated Plexiform Neurofibromas: A Network Meta-analysis"
-
Mr. Kakde has nothing to disclose.
-
Dr. Kakde has nothing to disclose.
-
Dr. Kaurani has nothing to disclose.
-
Dr. Upadhyay has nothing to disclose.
-
Dr. Ramteke has nothing to disclose.
-
Dr. Khan has nothing to disclose.